Amgen Inc. (NASDAQ: AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, ...
Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...
You're five times more likely to contract bowel cancer if two very particular factors are present, according to a new ...
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
AstraZeneca and Amgen secure CHMP support for Tezspire in nasal polyps and Koselugo in neurofibromatosis after strong Phase 3 ...
A new study reveals that popular low-carb, low-fiber diets may significantly increase the risk of colorectal cancer, ...
“Screening allows us to detect cancer early. Colorectal cancer often begins with small growths in the intestine called polyps. Each polyp has a 30 to 40 percent chance of developing into cancer. If we ...
Their life cycle can repeat many times, and in perfect conditions, these jellyfish could avoid aging altogether.
Nasir Rajpoot, CEO and CSO of Histofy, reveals AI-powered screening and the triaging processes for large bowel endoscopic ...
Day Fiancé stars Julia Trubkina and Brandon Gibbs are on the road to parenthood. Back in August, when the TLC stars announced her pregnancy, they described it as “exciting and a little surreal.” Read ...
At a lab in the heart of San Francisco's Golden Gate Park, scientists are breeding corals to be more resilient to rising ...
Zacks.com on MSN
AZN Gets CHMP Nod for Label Expansion of Koselugo & Tezspire
AstraZeneca wins CHMP backing for label expansions of Koselugo in adult NF1 PN patients and Tezspire in chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results